Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin in CP/CPPS
NCT00740779Phase 2Completed
- Sponsor
- Watson Pharmaceuticals
- Start
- Sep 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of silodosin in chronic prostatitis chronic pelvic pain syndrome (CP/CPPS) (3 arms), sponsored by Watson Pharmaceuticals. Primary endpoint: National Institutes of Health-Chronic Prostatitis Symptom Index Total Score at 12 weeks. Started Sep 2008; status: completed.
02
Drugs
silodosin
03
Conditions
chronic prostatitis chronic pelvic pain syndrome (CP/CPPS)
Beyond the preview
Go deeper on NCT00740779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00740779.